Arkolith/Insider Trading/KRYS/Form 4

Thomas John Charles

EVP, General CounselKrystal Biotech, Inc. (KRYS) · full profile →Form 4 · filed May 27, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$194K
Net Open-Market Flow
-$194K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 26, 2026Sell(S)642$302.03$194K0

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0002114900-26-000006) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML